Bayesian Statistics Approach Offers Benefits To Sponsors, FDA Staffers Say
This article was originally published in The Gray Sheet
Executive Summary
Use of Bayesian statistics in designing Guidant's Multi-Link Duet stent trial would have halved the number of enrollees required for FDA approval, according to Guidant Senior Biostatistician Frank Hu.
You may also be interested in...
CDRH Promotes Bayesian Tool To Speed Approvals; Statistical Rigor Required
FDA is encouraging medical device firms to consider using Bayesian estimation in clinical trials to streamline regulatory timeframes
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.